GenSight Biologics S.A.
EPA:SIGHT.PA
0.315 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| -26.22 | -27.625 | -28.617 | -34.015 | -30.71 | -33.453 | -24.112 | -22.082 | -13.654 | -6.671 | -2.763 |
Depreciation & Amortization
| 3.034 | 1.061 | 0.928 | 0.926 | 0.985 | 0.315 | 0.224 | 0.203 | 0.139 | 0.256 | 0.04 |
Deferred Income Tax
| -8.89 | 0 | 0.017 | 0.036 | 0.035 | 0.027 | 0.027 | 0.031 | 0.029 | 0 | 0 |
Stock Based Compensation
| 0.587 | -3.364 | 4.834 | 3.455 | 1.307 | 2.422 | 4.8 | 4.635 | 1.532 | 0.295 | 0.131 |
Change In Working Capital
| 2.454 | -3.916 | 4.841 | 5.567 | -0.145 | 1.896 | 0.202 | -2.429 | -0.129 | 0.59 | 0.642 |
Accounts Receivables
| -0.001 | 0.756 | -0.698 | 0.791 | -0.844 | -3.469 | -0.957 | 0.97 | -2.858 | -0.53 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -2.234 | -2.152 | 2.398 | 0.344 | -0.223 | 5.233 | 0.384 | -3.459 | 3.283 | 0 | 0 |
Other Working Capital
| 4.689 | -2.52 | 3.141 | 4.432 | 0.922 | 0.132 | 0.775 | 0.06 | -0.555 | 0.585 | -0.606 |
Other Non Cash Items
| 4.004 | 0.091 | 0.858 | 8.987 | 0.416 | 0.41 | 0.077 | -0 | -0.012 | 0.015 | 1.264 |
Operating Cash Flow
| -25.031 | -33.753 | -17.139 | -15.044 | -28.112 | -28.383 | -18.782 | -19.642 | -12.095 | -5.516 | -1.95 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -0.01 | -0.252 | -0.032 | -0.006 | -0.076 | -0.791 | -0.236 | -0.189 | -0.707 | -0.189 | -0.343 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.011 | 0.008 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | -0.37 | -0.026 | 0 | -0.448 | 0 | -0.08 | -1.402 | -0.031 |
Sales Maturities Of Investments
| 0.219 | 0.424 | 0.016 | 0 | 0 | 0.128 | 0 | 0.008 | 1.404 | 0 | 0 |
Other Investing Activites
| 0.219 | 0.424 | 0.016 | -0.37 | -0.033 | 0.128 | -0.448 | 0.011 | -0.008 | -1.402 | -0.032 |
Investing Cash Flow
| 0.209 | 0.172 | -0.016 | -0.376 | -0.102 | -0.663 | -0.684 | -0.17 | 0.617 | -1.591 | -0.374 |
Financing Activities: | |||||||||||
Debt Repayment
| -13.101 | -7.822 | -3.069 | -11.711 | -5.672 | 0 | 0 | -2.3 | 0 | -0.678 | 0 |
Common Stock Issued
| 4.017 | 0.037 | 28.533 | 23.567 | 16.222 | 0.008 | 21.031 | 41.58 | 30.868 | 0.006 | 19.399 |
Common Stock Repurchased
| -0.099 | -0.193 | -0.305 | 0 | 0 | -0.123 | -0.084 | -0.145 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 3.649 | 8.266 | -0.001 | 22.003 | 10.695 | 0.008 | -0.001 | 2.3 | 30.868 | 0.678 | 19.399 |
Financing Cash Flow
| 16.227 | 0.095 | 23.739 | 33.859 | 21.245 | -0.115 | 20.946 | 43.735 | 30.868 | 0.684 | 19.399 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 0.119 | -0.193 | -0.238 | 0.254 | -0.022 | -0.047 | -0.014 | -0 | 0 | 0 | 0 |
Net Change In Cash
| -8.476 | -33.679 | 6.345 | 18.693 | -6.991 | -29.207 | 1.466 | 23.922 | 19.39 | -6.424 | 17.075 |
Cash At End Of Period
| 2.134 | 10.609 | 44.288 | 37.943 | 19.25 | 26.241 | 55.448 | 53.982 | 30.06 | 10.669 | 17.093 |